Bloodletting

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Classic bleeding procedure. Rheological measure for isovolaemic dilution.

Effects
This section has been translated automatically.

The extracted volume is replaced by reabsorption from the tissue. This decongestion improves the microcirculation.

Indication
This section has been translated automatically.

Indicated by conventional medicine for porphyria cutanea tarda and polycythemia vera. Naturopathically also for over-nourished patients, metabolic diseases such as obesity, gout, diabetes mellitus, hyperlipidemia, diseases with a Hkt > 40% and a Hb of > 145 g/l. Also for cardiovascular diseases, breathing difficulties, shortness of breath, dizziness, sweating and circulatory disorders of the brain. Venous stasis corresponding to chronic venous insufficiency Venous insufficiency, chronic.

Implementation
This section has been translated automatically.

Collection of up to 100-300 ml of blood 1-2 times/week from the arm vein, control of the crit. For porphyria cutanea tarda and polycythaemia vera up to 500 ml/week.

Contraindication
This section has been translated automatically.

Anemia, dehydration, acute diarrhea, hypotension. Physically debilitated patients.

Notice! Bloodletting therapy is indicated for fullness types, not empty types.

Incoming links (1)

Gout;